FDA Drug recall D-0113-2024
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39)…
- FDA Drug
- Class III
- terminated
- Published 2023-11-29
On 2023-11-29 the FDA classified a Class III recall of Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39)… by Ncs Healthcare, citing presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0113-2024 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2023-10-27 |
| Published | 2023-11-29 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Ncs Healthcare |
| Distribution | US |
Product
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.
Reason
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Identifiers
| ndc | 0615-7714-39 |
|---|---|
| ndc | 0615-7714-05 |
| ndc | 0615-7714-30 |
| ndc | 0615-7718-39 |
| ndc | 0615-7718-31 |
| ndc | 0615-7718-05 |
| ndc | 0615-7718-28 |
| ndc | 0615-7689-39 |
| ndc | 0615-7689-31 |
| ndc | 0615-7689-05 |
| code_info | Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0113-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.